Business · 29/10/2015Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Guidance for Adverse Event Reporting for Outsourcing Facilities
Summary
The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a new guidance document on adverse event reporting for outsourcing facilities, as required by the Paperwork Reduction Act of 1995
Original source language: Federal Register — Food and Drug AdministrationOpen original release →